Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular TestsBusiness Wire • 12/16/24
Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual ConferenceBusiness Wire • 11/12/24
Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular TestsBusiness Wire • 10/01/24
Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular SolutionsBusiness Wire • 07/29/24
Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, IllinoisBusiness Wire • 06/27/24
Cardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics ForumBusiness Wire • 06/25/24
Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and ConfidentialityBusiness Wire • 06/10/24
Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services' (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative TestsBusiness Wire • 05/21/24
Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists' Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a WeekBusiness Wire • 05/13/24
Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million AnnuallyBusiness Wire • 04/29/24
Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in MichiganBusiness Wire • 04/09/24
Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with NavierreBusiness Wire • 04/04/24
Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology's 73rd Annual Scientific SessionBusiness Wire • 03/14/24
Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular DiseaseBusiness Wire • 03/05/24
Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide RolloutBusiness Wire • 02/15/24
Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart SupercentersBusiness Wire • 02/07/24
Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease TestsBusiness Wire • 02/05/24
Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic AdvisorBusiness Wire • 01/24/24
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™Business Wire • 01/04/24
Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™Business Wire • 01/04/24
American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease EventBusiness Wire • 01/03/24
American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.'s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement CodeBusiness Wire • 01/02/24
Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of DirectorsBusiness Wire • 12/21/23
Cardio Diagnostics Holdings, Inc. Regains Nasdaq Minimum Bid Price RequirementBusiness Wire • 12/06/23
